GAM-501

N/A

Report date: 2026/02/13 20:01:31

Base Information

Drug NameGAM-501
Drug Alias NameGAM-501
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector > Ad5 vector
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTaxus Cardium Pharmaceuticals Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTissue Repair CompanyTaxus Cardium Pharmaceuticals GroupCardium Therapeutics
Active IndicationsN/A
Inactive IndicationsDiabetic Foot

Other Information

ATC CodeN/A
Related LinksN/A